Stock Market Today, Feb.: ImmunityBio Surges on Anktiva
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Palantir is navigating a mix of headwinds and catalysts as 2026 unfolds. Here are three grounded predictions palantir...
A prominent hedge fund reduced its Wix stake by 25,000 shares in late 2025. This article breaks down what dorsal capi...
Stocks faced a rough start to the week as tariff headlines rattled markets and Nvidia prepares its earnings reveal. L...
In a day when many markets drifted lower, walmart stock topped market thanks to upbeat targets and steady demand. Thi...
Today’s trading session spotlighted PayPal as takeover rumors circulated, lifting the stock while the broader market ...
A major biotech setback on Feb. 23 spooked investors and nudged major indices lower. This piece breaks down what happ...
When a major IEEPA tariff ruling shifts policy, winners emerge in unexpected places, but the losers often reveal the ...
February isn’t just cold weather and bills—it's a crucial time for Medicare decisions. Retirees should double-check e...
Forward Air’s path to 2025 earnings rests on freight demand, margins, and disciplined cost management. This guide bre...
Investors preparing for the Q4 2025 call on tarsus (tars) 2025 earnings will want a clear, actionable plan. This guid...
Investors are rechecking fintech momentum as the stock market today, feb. delivers a choppy session. This guide break...